IL-33 exhibits dual functions in AKI, which may depend on the type of immune cells activated by IL-33 and the specific immune microenvironment, which will require more in-depth studies to elucidate the complex regulatory mechanisms of the IL-33/ST2 signaling pathway in AKI. Here, IL33 is linked to acute kidney injury.